Exclusive

Publication

Byline

Location

US Patent Issued to Pardes Biosciences on Sept. 29 for "Inhibitors of cysteine proteases and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,230, issued on Sept. 29, was assigned to Pardes Biosciences Inc. (Carlsbad, Calif.). "Inhibitors of cysteine proteases and methods of use ... Read More


US Patent Issued to CHIESI FARMACEUTICI on Sept. 29 for "(AZA)quinoline 4-amines derivatives as P2X 3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,231, issued on Sept. 29, was assigned to CHIESI FARMACEUTICI S.p.A. (Parma, Italy). "(AZA)quinoline 4-amines derivatives as P2X 3 inhibito... Read More


US Patent Issued to DENALI THERAPEUTICS on Sept. 29 for "Compounds, compositions, and methods" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,232, issued on Sept. 29, was assigned to DENALI THERAPEUTICS INC. (South San Francisco, Calif.). "Compounds, compositions, and methods" wa... Read More


US Patent Issued to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL on Sept. 29 for "GLP-1 receptor agonist and composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,233, issued on Sept. 29, was assigned to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL Co. LTD. (Zhejiang, China). "GLP-1 receptor agonist and c... Read More


US Patent Issued to Ohio State Innovation Foundation, REACTION BIOLOGY on Sept. 29 for "Kinase inhibitors for the treatment of neurodegenerative diseases" (Pennsylvania, Ohio Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,234, issued on Sept. 29, was assigned to Ohio State Innovation Foundation (Columbus, Ohio) and REACTION BIOLOGY Corp. (Malvern, Pa.). "Kin... Read More


US Patent Issued to Hoffmann-La Roche on Sept. 29 for "Triazolyl derivatives as GABA a Alpha5 PAM" (Swiss, French, German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,235, issued on Sept. 29, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.). "Triazolyl derivatives as GABA a Alpha5 PAM" was inven... Read More


US Patent Issued to Akagera Medicines on Sept. 29 for "Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,236, issued on Sept. 29, was assigned to Akagera Medicines Inc. (Waltham, Mass.). "Oxazolidinone compounds, liposome compositions comprisi... Read More


US Patent Issued on Sept. 29 for "Pyrazolyl compounds as KV7 channel activators" (Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,237, issued on Sept. 29. "Pyrazolyl compounds as KV7 channel activators" was invented by Lynn Resnick (Pittsburgh), James S. Hale (Pittsbu... Read More


US Patent Issued to NYRADA on Sept. 29 for "Compounds for treatment of excitotoxicity" (Australian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,238, issued on Sept. 29, was assigned to NYRADA PTY LTD (Sydney). "Compounds for treatment of excitotoxicity" was invented by Phillip Cogh... Read More


US Patent Issued to CHUGAI SEIYAKU on Sept. 29 for "Nitrogen-containing heterocyclic compound having MYT1 inhibitory activity" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,239, issued on Sept. 29, was assigned to CHUGAI SEIYAKU K.K. (Tokyo). "Nitrogen-containing heterocyclic compound having MYT1 inhibitory ac... Read More